Clinical Trials Arena March 8, 2024
GlobalData Healthcare

The US joins more than 100 countries where the contraceptive pill is available without a prescription.

Manufacturer Perrigo announced on 4 March that Opill (norgestrel), the first daily over-the-counter birth control pill, will be available in the US in the next few weeks.

Opill has been available by prescription for nearly 50 years, but last year, the Food and Drug Administration (FDA) approved Opill as a non-prescription oral contraceptive in the US. The cost of a one-month supply will be $19.99.

Opill is a progestin-only birth control pill, which is considered safer compared to other contraceptive drugs containing estrogen and progestin. Opill works by raising progestin levels, which leads to the thickening of the mucus in the cervix, preventing sperm...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
FDA Approves First Biosimilar to Omalizumab
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Roche builds in obesity with $5.3bn Zealand licensing deal

Share This Article